NEW YORK (GenomeWeb News) – At a public meeting held by the US Food and Drug Administration in Washington, DC, today focused on ways to create more transparency in agency affairs, the advocacy group Genetic Alliance advised the FDA to host a registry for genetic tests and lab tests, and that it share all of its warning letters with the public.

FDA held the meeting to listen to recommendations from the public about how to make information about its activities more useful, understandable, and accessible.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Heads of various research funding agencies discuss how to encourage scientific breakthroughs, ScienceInsider reports.

The Kansas City Star examines issues surrounding newborn genome sequencing.

Researchers say their Research Resource Identifier citation format is catching on, Nature News reports.

In Science this week: the Human Silencing Hub protein complex, and more.